Nothing Special   »   [go: up one dir, main page]

JO2092B1 - Pharmaceutical compositions for the controlled release of active substances - Google Patents

Pharmaceutical compositions for the controlled release of active substances

Info

Publication number
JO2092B1
JO2092B1 JO19982092A JOP19982092A JO2092B1 JO 2092 B1 JO2092 B1 JO 2092B1 JO 19982092 A JO19982092 A JO 19982092A JO P19982092 A JOP19982092 A JO P19982092A JO 2092 B1 JO2092 B1 JO 2092B1
Authority
JO
Jordan
Prior art keywords
matrices
composition
pharmaceutical compositions
mixtures
controlled release
Prior art date
Application number
JO19982092A
Other languages
Arabic (ar)
Inventor
فنارا دومنيكا
بيروير مونيك
بوكويلي آن
ديليرز ميشيل
Original Assignee
يو سي بي، اس. ايه.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by يو سي بي، اس. ايه. filed Critical يو سي بي، اس. ايه.
Priority to JO19982092A priority Critical patent/JO2092B1/en
Application granted granted Critical
Publication of JO2092B1 publication Critical patent/JO2092B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising a) the said at least one active substance, b) between 5 and 60% by weight, relative to the total weight of the composition, of at least one excipient, selected from inert matrices, hydrophilic matrices, lipid matrices, mixtures of inert matrices and of lipid matrices, mixtures of hydrophilic matrices and of inert matrices, with the exception of mixtures comprising a polyacrylic acid and at least one hydrophilic matrix of the cellulose type; ; c) between 5 and 50% by weight, relative to the total weight of the composition, of at least one alkalinizing agent soluble in an aqueous phase under physiological pH conditions, selected from alkali or alkaline-earth metal hydroxidcs, carbonates, bicarbonates and phosphates, sodium borate as well as the basic salts of organic acids. It also relates to processes for the preparation of said compositions, multi-layered pharmaceutical compositions comprising at least one layer with this composition, as well as processes for the preparation of said multi-layered composition.
JO19982092A 1998-08-19 1998-08-19 Pharmaceutical compositions for the controlled release of active substances JO2092B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO19982092A JO2092B1 (en) 1998-08-19 1998-08-19 Pharmaceutical compositions for the controlled release of active substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO19982092A JO2092B1 (en) 1998-08-19 1998-08-19 Pharmaceutical compositions for the controlled release of active substances

Publications (1)

Publication Number Publication Date
JO2092B1 true JO2092B1 (en) 2000-05-21

Family

ID=48093514

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19982092A JO2092B1 (en) 1998-08-19 1998-08-19 Pharmaceutical compositions for the controlled release of active substances

Country Status (1)

Country Link
JO (1) JO2092B1 (en)

Similar Documents

Publication Publication Date Title
HK1026152A1 (en) Pharmaceutical compositions for controlled release of active substances
JP5523647B2 (en) Oral administration of adenosine analog
ES2167921T5 (en) Enhanced multiparticulate tablet for rapid disintegration
CA2464250A1 (en) Kit for the preparation of a pharmaceutical composition
KR970701038A (en) CRANULAR PRODUCT OR TABLET CONTAINING AN EFFER VESCENT SYSTEM AND AN ACTIVE PHARMACEUTICAL SUBSTANCE, AS WELL AS A METHOD FOR ITS PREPARATION
US8426451B2 (en) Oral solid preparation and method of manufacturing the same
ES2288117B1 (en) SOLID PHARMACEUTICAL COMPOSITION OF GABAPENTINA.
ES2201460T3 (en) STABLE SOLID PREPARATION CONTAINING VITAMIN D3 AND TRICALCICO PHOSPHATE.
US6521262B2 (en) Solid instant-release forms of administration and process for producing the same
KR20010033938A (en) Disintegrating agent
JO2092B1 (en) Pharmaceutical compositions for the controlled release of active substances
GB1582162A (en) Stable prostaglandin composition and process for the preparation thereof
NO753674L (en)
JP2004527518A (en) Pravastatin stable drug composition
KR100741937B1 (en) Method of stabilizing preparation
US7148207B2 (en) Oral fludara of high-purity formulation with quick release of active ingredient
AR012266A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES AND PROCEDURE FOR THE PREPARATION.
TH36198A (en) Pharmaceutical compounds for controlling the release of active ingredients
NL8602139A (en) Inhibition of parathyroid hormone secretion.
MX2008016418A (en) Oral pharmaceutical composition of a poorly water-soluble active substance.